Lipase Levels and Coronavirus Disease 2019

Uşak University4,000 enrolled

Overview

Although COVID-19 disease due to Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects the respiratory tract, heart and coagulation system, symptoms of gastrointestinal system involvement such as abdominal pain, nausea, vomiting and diarrhea are also common. In this study, it was aimed retrospective analysis of clinical and laboratory data of patients who developed pancreatic injury and acute pancreatitis in the course of COVID 19 disease.

Study Type

OBSERVATIONAL

Enrollment

4,000

Conditions

Pancreatitis Lipase Increased

Interventions

Age, gender, hospitalization and mortality rates will be comparedOTHER

Age, gender, hospitalization and mortality rates will be compared

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with lipase levels measured during COVID-19 Exclusion Criteria: Patients with age \<18 years Patients with pregnancy Patients whose lipase levels were not measured in the course of COVID-19 Patients with known solid organ malignacy Patients with known hematologic malignacy

Locations (1)

Cevdet Duran

Uşak, Turkey (Türkiye)

Outcomes

Primary Outcomes

The frequency of lipase enzyme elevation will be compared

Time frame: From 31th March 2020 until 9th July 2021

The mortaliy rate will be compared

Time frame: From 31th March 2020 until 9th July 2021

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.